Evaluate Bioequivalence of Burotam (1/1 g/Vial)

Clinical trial NCT05654090 · UNKNOWN

Trial details

NCT number: NCT05654090
Sponsor: Yung Shin Pharm. Ind. Co., Ltd.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Infectious Diseases

Start date: 2022-08-25
Primary completion: 2022-11-18
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.